1. Home
  2. IMMR vs SLGL Comparison

IMMR vs SLGL Comparison

Compare IMMR & SLGL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Immersion Corporation

IMMR

Immersion Corporation

HOLD

Current Price

$6.78

Market Cap

207.5M

Sector

Technology

ML Signal

HOLD

Logo Sol-Gel Technologies Ltd.

SLGL

Sol-Gel Technologies Ltd.

HOLD

Current Price

$74.01

Market Cap

240.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
IMMR
SLGL
Founded
1993
1997
Country
United States
Israel
Employees
N/A
N/A
Industry
Computer peripheral equipment
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
207.5M
240.3M
IPO Year
1999
2016

Fundamental Metrics

Financial Performance
Metric
IMMR
SLGL
Price
$6.78
$74.01
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
1
Target Price
$13.50
$110.00
AVG Volume (30 Days)
601.9K
24.2K
Earning Date
04-13-2026
05-22-2026
Dividend Yield
5.11%
N/A
EPS Growth
N/A
N/A
EPS
0.02
N/A
Revenue
$35,013,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$223.84
P/E Ratio
$339.00
N/A
Revenue Growth
N/A
N/A
52 Week Low
$5.25
$6.96
52 Week High
$8.00
$97.97

Technical Indicators

Market Signals
Indicator
IMMR
SLGL
Relative Strength Index (RSI) 54.62 51.24
Support Level $6.30 $70.05
Resistance Level $6.91 $75.00
Average True Range (ATR) 0.29 4.78
MACD 0.02 -0.05
Stochastic Oscillator 62.92 39.73

Price Performance

Historical Comparison
IMMR
SLGL

About IMMR Immersion Corporation

Immersion Corp is focused on the creation, design, development, and licensing of haptic technologies that allow people to use its sense of touch more fully as it involves engaging with products and experience the digital world. The company's software focuses on applications in mobile devices, wearables, consumer, and gaming devices markets. It generates revenue from royalty and license fees, and development contract and service fees. Geographically, the company generates a majority of its revenue from Japan, followed by Korea, Germany, United States of America and other countries.

About SLGL Sol-Gel Technologies Ltd.

Sol-Gel Technologies Ltd is a dermatology company. It is engaged in identifying, developing and commercializing branded and generic topical drug products for the treatment of skin diseases. The company's product candidate pipeline includes SGT-610 (Patidegib Gel 2%), a new chemical entity hedgehog signaling pathway blocker, for the chronic use and prevention of new BCC in Gorlin syndrome patients, and the topical drug candidate SGT-210 for the treatment of Darier Disease and other rare keratosis-related indications such as PC, PPK and Olmsted. It generates the majority of its revenue from the United States.

Share on Social Networks: